Pharmacokinetics of cefoperazone in patients with neoplastic disease.

Pharmacokinetics of cefoperazone in patients with neoplastic disease.

Item
http://www.wikidata.org/entity/Q35670676
Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis.Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.Multiple-dose pharmacokinetics and toleration of intravenously administered cefoperazone and sulbactam when given as single agents or in combination.Antimicrobial activity, pharmacokinetics, adverse reactions, and therapeutic indications of cefoperazone.Determination of cefoperazone concentration in serum and muscle tissue with a versatile high-pressure liquid chromatographic method.Pharmacokinetics of cefoperazone and sulbactam in liver transplant patients.Treatment of gram-negative bacillary septicemia with cefoperazone.
P2860

Pharmacokinetics of cefoperazone in patients with neoplastic disease.

Item
http://www.wikidata.org/entity/Q35670676
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
Pharmacokinetics of cefoperazone in patients with neoplastic disease.
@ast
Pharmacokinetics of cefoperazone in patients with neoplastic disease.
@en
type
label
Pharmacokinetics of cefoperazone in patients with neoplastic disease.
@ast
Pharmacokinetics of cefoperazone in patients with neoplastic disease.
@en
prefLabel
Pharmacokinetics of cefoperazone in patients with neoplastic disease.
@ast
Pharmacokinetics of cefoperazone in patients with neoplastic disease.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
Pharmacokinetics of cefoperazone in patients with neoplastic disease.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932